Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization

Clinical trial NCT00645697 · COMPLETED

Trial details

NCT number: NCT00645697
Sponsor: Rafic Hariri University Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Neovascularization Tuberculosis Multifocal Serpiginous Choroiditis Harada Toxoplasmosis

Start date: 2007-01-01
Primary completion: 2008-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.